- Report
- May 2024
- 133 Pages
Global
From €5831EUR$6,499USD£5,019GBP
- Report
- February 2025
- 186 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Report
- April 2021
China
From €2333EUR$2,600USD£2,008GBP
- Report
- August 2022
- 117 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Drug Pipelines
- February 2024
- 80 Pages
Global
From €1795EUR$2,000USD£1,545GBP
- Report
- April 2023
- 147 Pages
Global
From €4441EUR$4,949USD£3,822GBP
- Report
- September 2024
- 80 Pages
Japan
From €3140EUR$3,500USD£2,703GBP
- Report
- November 2023
- 185 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Report
- April 2023
- 115 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €449EUR$500USD£386GBP
- Report
- November 2021
- 620 Pages
Global
From €3589EUR$4,000USD£3,089GBP
Tamiflu (oseltamivir) is an antiviral medication used to treat and prevent influenza (flu) caused by influenza A and B viruses. It is a neuraminidase inhibitor, which works by blocking the activity of the virus in the body. Tamiflu is approved for use in adults and children over the age of two weeks. It is available in capsule and liquid form.
Tamiflu is one of the most widely used drugs for the treatment and prevention of influenza. It is used in both outpatient and inpatient settings, and is recommended by the Centers for Disease Control and Prevention (CDC) for the treatment of influenza. It is also used to reduce the risk of complications from influenza, such as pneumonia and hospitalization.
Tamiflu is marketed by several pharmaceutical companies, including Roche, GlaxoSmithKline, and Sanofi. It is also available as a generic drug, which is manufactured by several generic drug companies. Tamiflu is available in many countries around the world, including the United States, Canada, Europe, and Asia. Show Less Read more